First Time Loading...

Eisai Co Ltd
TSE:4523

Watchlist Manager
Eisai Co Ltd Logo
Eisai Co Ltd
TSE:4523
Watchlist
Price: 5 901 JPY 1.32% Market Closed
Updated: Apr 19, 2024

Intrinsic Value

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. [ Read More ]

The intrinsic value of one Eisai Co Ltd stock under the Base Case scenario is 7 616.6 JPY. Compared to the current market price of 5 901 JPY, Eisai Co Ltd is Undervalued by 23%.

Key Points:
Intrinsic Value
Base Case
7 616.6 JPY
Undervaluation 23%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Eisai Co Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling Eisai Co Ltd stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Eisai Co Ltd

Provide an overview of the primary business activities
of Eisai Co Ltd.

What unique competitive advantages
does Eisai Co Ltd hold over its rivals?

What risks and challenges
does Eisai Co Ltd face in the near future?

Summarize the latest earnings call
of Eisai Co Ltd.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Eisai Co Ltd.

Provide P/S
for Eisai Co Ltd.

Provide P/E
for Eisai Co Ltd.

Provide P/OCF
for Eisai Co Ltd.

Provide P/FCFE
for Eisai Co Ltd.

Provide P/B
for Eisai Co Ltd.

Provide EV/S
for Eisai Co Ltd.

Provide EV/GP
for Eisai Co Ltd.

Provide EV/EBITDA
for Eisai Co Ltd.

Provide EV/EBIT
for Eisai Co Ltd.

Provide EV/OCF
for Eisai Co Ltd.

Provide EV/FCFF
for Eisai Co Ltd.

Provide EV/IC
for Eisai Co Ltd.

Show me price targets
for Eisai Co Ltd made by professional analysts.

What are the Revenue projections
for Eisai Co Ltd?

How accurate were the past Revenue estimates
for Eisai Co Ltd?

What are the Net Income projections
for Eisai Co Ltd?

How accurate were the past Net Income estimates
for Eisai Co Ltd?

What are the EPS projections
for Eisai Co Ltd?

How accurate were the past EPS estimates
for Eisai Co Ltd?

What are the EBIT projections
for Eisai Co Ltd?

How accurate were the past EBIT estimates
for Eisai Co Ltd?

Compare the revenue forecasts
for Eisai Co Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Eisai Co Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Eisai Co Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Eisai Co Ltd compared to its peers.

Compare the P/E ratios
of Eisai Co Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Eisai Co Ltd with its peers.

Analyze the financial leverage
of Eisai Co Ltd compared to its main competitors.

Show all profitability ratios
for Eisai Co Ltd.

Provide ROE
for Eisai Co Ltd.

Provide ROA
for Eisai Co Ltd.

Provide ROIC
for Eisai Co Ltd.

Provide ROCE
for Eisai Co Ltd.

Provide Gross Margin
for Eisai Co Ltd.

Provide Operating Margin
for Eisai Co Ltd.

Provide Net Margin
for Eisai Co Ltd.

Provide FCF Margin
for Eisai Co Ltd.

Show all solvency ratios
for Eisai Co Ltd.

Provide D/E Ratio
for Eisai Co Ltd.

Provide D/A Ratio
for Eisai Co Ltd.

Provide Interest Coverage Ratio
for Eisai Co Ltd.

Provide Altman Z-Score Ratio
for Eisai Co Ltd.

Provide Quick Ratio
for Eisai Co Ltd.

Provide Current Ratio
for Eisai Co Ltd.

Provide Cash Ratio
for Eisai Co Ltd.

What is the historical Revenue growth
over the last 5 years for Eisai Co Ltd?

What is the historical Net Income growth
over the last 5 years for Eisai Co Ltd?

What is the current Free Cash Flow
of Eisai Co Ltd?

Financials

Balance Sheet Decomposition
Eisai Co Ltd

Current Assets 661B
Cash & Short-Term Investments 285.2B
Receivables 186.2B
Other Current Assets 189.6B
Non-Current Assets 650.2B
Long-Term Investments 58.6B
PP&E 159.9B
Intangibles 307.8B
Other Non-Current Assets 123.9B
Current Liabilities 277.8B
Accounts Payable 56.1B
Other Current Liabilities 221.7B
Non-Current Liabilities 214.6B
Long-Term Debt 134.8B
Other Non-Current Liabilities 79.8B
Efficiency

Earnings Waterfall
Eisai Co Ltd

Revenue
749.5B JPY
Cost of Revenue
-157.8B JPY
Gross Profit
591.7B JPY
Operating Expenses
-525.7B JPY
Operating Income
65.9B JPY
Other Expenses
-20.5B JPY
Net Income
45.4B JPY

Free Cash Flow Analysis
Eisai Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
What is Free Cash Flow?
Fundamental Scores

Profitability Score
Profitability Due Diligence

Eisai Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Positive Free Cash Flow
Positive Revenue Growth Forecast
Positive 3-Years Revenue Growth
51/100
Profitability
Score

Eisai Co Ltd's profitability score is 51/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Eisai Co Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
Low D/E
High Altman Z-Score
Long-Term Solvency
83/100
Solvency
Score

Eisai Co Ltd's solvency score is 83/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Eisai Co Ltd

Wall Street analysts forecast Eisai Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Eisai Co Ltd is 8 083.42 JPY with a low forecast of 5 656 JPY and a high forecast of 11 130 JPY.

Lowest
Price Target
5 656 JPY
4% Downside
Average
Price Target
8 083.42 JPY
37% Upside
Highest
Price Target
11 130 JPY
89% Upside
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

Price
Eisai Co Ltd

1M 1M
-7%
6M 6M
-28%
1Y 1Y
-23%
3Y 3Y
-16%
5Y 5Y
+1%
10Y 10Y
+83%
Annual Price Range
5 901
52w Low
5 824
52w High
10 795
Price Metrics
Average Annual Return 9.87%
Standard Deviation of Annual Returns 19.75%
Max Drawdown -59%
Shares Statistics
Market Capitalization 1.7T JPY
Shares Outstanding 286 806 000
Percentage of Shares Shorted
N/A

Return Decomposition
Main factors of price return

What is price return decomposition?

News

Other Videos

Last Important Events
Eisai Co Ltd

Significant happenings or occurrences that are of interest to investors. These could be company-specific developments or market-wide shifts.

All
Positive
Negative

Sentiment Analysis
Eisai Co Ltd

Today
Last 7 Days 7D
Last 30 Days 30D
Last 90 Days 90D

Company Profile

Eisai Co Ltd Logo
Eisai Co Ltd

Country

Japan

Industry

Pharmaceuticals

Market Cap

1.7T JPY

Dividend Yield

2.75%

Description

Eisai Co., Ltd. engages in the development, manufacture, and sale of prescription medicines and over-the-counter products. The company is headquartered in Bunkyo-Ku, Tokyo-To and currently employs 11,237 full-time employees. The firm operates in two business segments. The Pharmaceutical segment is engaged in the research, development, manufacture and sale of pharmaceuticals for medical use, generic drugs, general medicines, among others. The segment operates in five regions including Japan, Americas (North America), China, EMEA (Europe, Middle East, Africa, Oceania), Asia and Latin America (South Korea, Taiwan, Hong Kong, India, ASEAN, Latin America). The Others segment is involved in license revenues and pharmaceutical raw materials business. The firm is also engaged in the provision of brands such as the anticancer drugs Lembima and Halaven on the nerve and oncology areas.

Contact

TOKYO-TO
Bunkyo-ku
Eisai Main Bldg., 4-6-10, Koishikawa
+81338173700.0
https://www.eisai.co.jp/

IPO

1961-09-14

Employees

11 237

Officers

CEO, Representative Corporate Officer & Director
Mr. Haruo Naito
Senior VP & President of EMEA Region
Mr. Gary Hendler
Vice President & Chief Clinical Officer - Alzheimer's Disease and Brain Health
Dr. Lynn D. Kramer FAAN, M.D.
Senior Vice President
Ms. Yanhui Feng
President
Dr. Nadeem Sarwar Ph.D.
VP & CFO
Mitsuru Shomon
Show More
Representative Corporate Officer, COO, Industry Affairs, China Business & Data Integrity
Mr. Yasushi Okada
VP & Chief Information Officer
Makoto Hoketsu
Chief Gov. Rel. and IR Officer, SVP of Global Value, Acc., Japan Subs, General, Env. & Safety Aff.
Mr. Masatomi Akana
Executive VP of IP, Internal Audit & Control, General Counsel and Chief Compliance Officer
Mr. Kenta Takahashi
Show Less

See Also

Discover More
What is the Intrinsic Value of one Eisai Co Ltd stock?

The intrinsic value of one Eisai Co Ltd stock under the Base Case scenario is 7 616.6 JPY.

Is Eisai Co Ltd stock undervalued or overvalued?

Compared to the current market price of 5 901 JPY, Eisai Co Ltd is Undervalued by 23%.